Faegre Baker Daniels – Medical Alley Association

Faegre Baker Daniels

In the Know: Healthcare News for Nov. 18, 2019

New Abbott Labs CEO has deep background in medical devices Possible Faegre Baker Daniels merger would form one of nation’s top 50 law firms Workforce, job creation and startups among Greater MSP’s top priorities Optum CEO named UnitedHealth Group president Excelera Joins Medical Alley Association to Influence Positive Change for Complex Patient Care Made in […]

3D Printing: Product Liability Risk at the Point of Care

By Joe Winebrenner and Andrew Jackson Over the last decade, 3D printing (also known as “additive manufacturing”) has revolutionized the medical industry. The FDA has reviewed hundreds of medical devices made with 3D printers, including orthopedic and cranial implants, surgical instruments, dental restorations, and prosthetic devices. With greater frequency, 3D printing technology is being incorporated […]

In the Know: Healthcare News for Nov. 4, 2019

Bio-Techne will open $40M+ facility in St. Paul IBM, Mayo Clinic, Geisinger among 25 finalists for $1.6M CMS artificial intelligence challenge Medtronic wins FDA breakthrough nod for fully implantable LVAD Minnesota Startups Raised $70.8M in Q3 Boston Sci Gives Update on the Measured Launch of Lotus Edge Meet The Most Disruptive MBA Startups Of 2019 […]

Launching a Medtech Product? Have Your Regulatory, IP and Governance Affairs in Order Before Engaging Investors

By Walter Linder, Amy Judge-Prein, and Jonathan Zimmerman Investors in medtech companies are willing to take risks. However, they will expect their investment to be put to effective use with defined objectives, and their diligence will focus on identifying potential impediments to those objectives. Because momentum is important when seeking investment, it is critical that […]

Telehealth State of the States

By Sarah-Lloyd Stevenson In the Midwest and across the country, state governments are recognizing that telehealth is a viable and affordable option for providing healthcare services to patients and their communities. In recent years, nearly every state has taken a step toward improving the coverage or reimbursement of telehealth. However, policies look very different from […]

“AI” And “IP”: Two Small Letters with Big Impact

By Lauren J.F. Barta and Timothy E. Grimsrud Artificial Intelligence is already used in healthcare in a multitude of ways, including robotic-assisted surgery, virtual nursing assistants, diagnostics, drug discovery, hospital workflow, consumer integrated health, and personalized medicine, and its use is only expected to grow.[1] AI technologies are able to sense, comprehend, act, and learn—this […]

Know Your Rights Before Publicly Discussing a Patent or Patent Application

When police arrest a suspect, they are required to advise the suspect of his right to remain silent. A recent decision on CRISPR from the U.S. Court of Appeals for the Federal Circuit suggests that applicants for U.S. patents could also benefit from remaining silent.  Under U.S. patent law, a person is entitled to patent […]

The Legal Risks of Genetic Data

By Christin Jaye Eaton and Jeff Wojciechowski Recent scientific and technological breakthroughs have enabled medical product manufacturers to analyze genetic data, which can unveil links between genetic traits and certain reactions to drugs or other products. But when must manufacturers use that data? What action must a manufacturer take when genetic data illuminates patient risk? […]

Keep your finger on the pulse of Medical Alley from anywhere with the ALLEY NEWSLETTER